期刊文献+

IL-10对HaCaT细胞中VEGF-A表达的影响

IL-10 inhibits the expression of VEGF-A in HaCaT cells
下载PDF
导出
摘要 目的探讨白介素-10(IL-10)对皮肤角质形成(HaCaT)细胞中血管内皮生长因子A(VEGF-A)表达的影响及其可能机制。方法培养HaCaT细胞,用不同剂量IL-10刺激后,通过荧光定量PCR(Real-time PCR)在mRNA水平上分析IL-10对HaCaT细胞中VEGF-A表达的影响;通过Western blot法分析IL-10对HaCaT细胞信号通路:丝裂原蛋白激活激酶-胞外信号调节激酶(MAPKs-ERK1/2)及磷脂酰肌醇激酶-丝氨酸/苏氨酸激酶(PI3K-AKT)的影响,并通过MAPKs-ERK1/2特异性阻断剂PD98059及PI3K-AKT特异性阻断剂LY294002阻断这两个信号途径,进而分析IL-10影响HaCaT细胞中VEGF-A表达的可能机制。结果 Real-time PCR分析结果显示IL-10能抑制HaCaT细胞中VEGF-A转录水平的表达;Western blot法结果显示:IL-10能够增加ERK1/2和AKT的磷酸化水平。阻断剂研究显示IL-10抑制VEGF-A转录水平表达的作用不依赖MAPKs-ERK1/2和PI3K-AKT途径。结论 IL-10抑制HaCaT细胞中VEGF-A转录水平的表达,不依赖MAPKs-ERK1/2和PI3K-AKT途径发挥作用。 Objective To explore the effect of IL-10 on VEGF-A in HaCaT cells. Methods HaCaT cells were clutured and treated with various concentration of IL-10 for different time. Real-time PCR was performed to detect the level of the VEGF-A mRNA; Western blot were used to analyzed signaling pathway activated by IL-10, inclu- ding mitogen-activation protein kinase-extracellular signal-regulated kinase (MAPKs-ERK1/2) and phosphatidyli- nositol kinase-serine/threonine kinases (PI3K-AKT). The specific inhibitors of the ERK1/2 and AKT phosphoryla- tion were used to detect the mechanism of the effect of IL-10 on the expression of VEGF-A. Results Our results showed that that IL-10 could inhibit the expression of VEGF-A. After IL-10 was stimulated, the IL-10 could in- crease the phosphorylation of ERK1/2 and AKT. The studies of the inhibitors of ERK1/2 (PD98059) and AKT (LY294002) showed the effect of IL-10 on the VEGF-A was independent of the MAPKs-ERK1/2 and PI3K-AKT signaling pathway. Conclusion The IL-10 can inhibit the expression of VEGF-A in HaCaT cells, and this effect of the IL-10 is independent of the MAPKs-ERK1/2 and PI3K-AKT signaling pathway.
出处 《安徽医科大学学报》 CAS 北大核心 2013年第8期864-867,共4页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金(编号:81271748)
关键词 HACAT细胞 IL-10 VEGF—A 信号途径 HaCaT cells IL-10 VEGF-A signal pathway
  • 相关文献

参考文献12

  • 1Zhou J H, Broussard S R, Strle K, et al. IL-10 Inhibits apoptosis of promyeloid cells by activating insulin receptor substrate-2 and phosphatidylinositol 3'-kinasel [ J ]. J Immunol, 2001, 167 ( 8 ) : 4436 - 42.
  • 2Weiss E, Mamelak A J, La Morgia S, et al. The role of interleu- kin 10 in the pathogenesis and potential treatment of skin diseases [J]. J Am Acad Dermatol, 2004, 50(5) : 657 -75.
  • 3满孝勇,郑敏.银屑病发病机制的研究进展[J].浙江大学学报(医学版),2006,35(6):673-677. 被引量:10
  • 4Altenburger R, Kissel T. The human keratinocyte cell line HaCaT: an in vitro cell culture model for keratinocyte testosterone metabolism[J]. Pharm Res, 1999, 16(5) : 766 -71.
  • 5朱崇涛,彭代智,周新,刘敬,罗海水,王丽华,王勇,蒋丽莉.以HaCaT细胞为种子细胞构建新型人组织工程皮肤[J].现代生物医学进展,2007,7(6):817-818. 被引量:9
  • 6夏阳,戴夫,彭琼.IL-10对TNF-α诱导肝星状细胞激活的抑制作用[J].安徽医科大学学报,2012,47(9):1032-1036. 被引量:4
  • 7Docke W D, Asadullah K, Belbe G, et al. Comprehensive bio- marker monitoring in cytokine therapy: heterogeneous, time-de- pendent, and persisting immune effects of interleukin-10 applica- tion in psoriasis[J]. J Lecukoc Biol, 2009, 85(3) : 582 -93.
  • 8姜海燕,方栩.白介素在银屑病发病机制中的研究新进展[J].国外医学(皮肤性病学分册),2003,29(5):288-290. 被引量:4
  • 9Sun J, Turner A, Xu J, et al. Genetic variability in inflammation pathways and prostate cancer risk[ J]. Urol Oncol, 2007,25 (3) : 250 - 9.
  • 10Ohm J E, Carbone D P. VEGF as a mediator of tumor-associated immunodeficiency[ J]. Immunol Res, 2001, 23 (2 - 3 ) : 263 - 72.

二级参考文献35

  • 1蔡绥勍,陈丽荣,王海军,姚丽芳,郑敏.磷酸化STAT3和p53基因在表皮肿瘤的表达[J].浙江大学学报(医学版),2004,33(4):331-334. 被引量:4
  • 2杨燕妮,彭代智,伍素华,周新,刘敬,董增学.异种无细胞真皮制备方法比较及在移植中的意义[J].中国临床康复,2004,8(23):4772-4773. 被引量:9
  • 3郑敏.银屑病发病机制研究中若干问题的思考[J].中华皮肤科杂志,2006,39(3):121-123. 被引量:104
  • 4Wei L, Debets B, Hegmans JJ, et al. IL - 1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-ganuna up-regulates the expression of keratin 17 and keratinocyte transg]utaminase via endogenous IL - 1 production. J Pathol, 1999, 187(3) :358 -364.
  • 5el Barnawi NY, Giasuddin AS, Ziu MM, et al. Serum cytokine levels in psoriasis vulgaris. Br J Biomed Sci, 2001,58(1) :40 -44.
  • 6Schon M, Behmenburg C, Denser D, et al. Pathogenic function of IL -1 beta in psoriasiform skin lesions of flaky skin (fsn/fsn) mice.Clin Exp Immunol, 2001, 123(3) .505 -510.
  • 7Nishibu A, Han GW, Iwatsuki K, et al. Overexpreasion of monocytederived cytokines in active psoriasis: a relation to coexistent arthropathy. J Dermatol Sci,1999, 21 ( 1 ) :63 -70.
  • 8Duan H, Koga T, Kohda F, et al. Interleukin-8- positive neutrophils in psoriasis. J Dermatol Sci, 2001,26(2) :119 -124.
  • 9Szepietowski J, Walker C, Hunter JA, et al. Elevated leukaemia inhibitory factor (LIF) expression in lesional psoriatic skin: correlation with interleukin (IL) -8 expression. J Dermatol, 2001,28(3) :115- 122.
  • 10Asadullah K, Docke WD, Ebeling M, et al. Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial. Arch Dermatol, 1999,135(2) :187 - 192.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部